Skip to content

Clinical trials

Phase 2 Hypersensitivity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20101
20121
20142
20181
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ALK-Abelló A/S2
AstraZeneca2
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
Allergopharma GmbH & Co. KG1
Cytos Biotechnology AG1
Hannover Medical School1
Stallergenes Greer1
T-Balance Therapeutics GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity13
Immune System Diseases3
Asthma2
Hematologic Diseases2
Immune Complex Diseases2
Mastocytosis2
Mastocytosis, Systemic2
Neoplasms2
Bronchial Diseases1
Dust Mite Allergy1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.